Search
Nexgel Inc
NXGLAdd to Watchlist
0.501USD
-0.021-4.06%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
4.62MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-30The current earnings forecast score of Nexgel Inc is 8.00, ranking 56 out of 157 in the Pharmaceuticals industry. The average price target is 6.00, with a high of 6.00 and a low of 6.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
2.000
Target Price
+283.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Nexgel Inc
NXGL
1
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
34
AbbVie Inc
ABBV
33
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Nexgel Inc's expected revenue for the next quarter?
Nexgel Inc's expected revenue is 4.32M.
What is Nexgel Inc's price target?
Analysts forecast that Nexgel Inc's price target is USD 6.00, with the highest forecast at USD 6.00 and the lowest forecast at USD 6.00.
How have Nexgel IncNXGL's recent earnings per share performed?
The market expectation was USD -0.11, while Nexgel IncNXGL's earnings per share (EPS) for the previous quarter was USD -0.12. EPS for the next quarter is expected at USD -0.12.
What is the analyst rating for Nexgel Inc?
Based on the ratings of Nexgel Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
